A recent study highlighted the importance of a hyperactive inflammatory response present in cancer patients, suggesting that a prognostic score, which includes NLR, PLR, C-reactive protein, and mGPS, could be used to assess the outcome of most cancers. This evidence concerns the gene CRP and cancer.